Evidence map›Paper›PMID 42292655›Full record

ArticleThe journal of allergy and clinical immunology. Global2026

Extended multisystem manifestations of hereditary α-tryptasemia in an allergy center cohort.

Daniel Koch, Friederike Wortmann, Andreas Recke, Ellen Rose, Evelyn Gaffal, Jennifer Wigger, Nikolas von Bubnoff, Dagmar von Bubnoff

Abstract read
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel KochDepartment of Dermatology, Allergology, and Venerology, University Hospital Schleswig-Holstein, Lübeck, Germany.
Friederike WortmannDepartment of Hematology and Oncology, University Hospital and University Cancer Center Schleswig-Holstein, Lübeck, Germany.
Andreas ReckeDepartment of Dermatology, Allergology, and Venerology, University Hospital Schleswig-Holstein, Lübeck, Germany.
Ellen RoseDepartment of Dermatology, Allergology, and Venerology, University Hospital Schleswig-Holstein, Lübeck, Germany.
Evelyn GaffalDepartment of Dermatology, Allergology, and Venerology, University Hospital Schleswig-Holstein, Lübeck, Germany.
Jennifer WiggerDepartment of Hematology and Oncology, University Hospital and University Cancer Center Schleswig-Holstein, Lübeck, Germany.
Nikolas von BubnoffDepartment of Hematology and Oncology, University Hospital and University Cancer Center Schleswig-Holstein, Lübeck, Germany.
Dagmar von BubnoffDepartment of Dermatology, Allergology, and Venerology, University Hospital Schleswig-Holstein, Lübeck, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hereditary α-tryptasemia (HαT) is a common autosomal-dominant trait caused by additional copies of the gene Objective: We sought to delineate the spectrum and burden of extended manifestations observed in patients with and without HαT presenting to an allergy department. Methods: A total of 332 allergy patients with BST ≥ 8 μg/L were prospectively enrolled. Blood was tested for HαT and Results: HαT-positive patients reported a significantly higher symptom burden than HαT-negative patients (9.3 vs 6.5; Conclusion: HαT may have a broader clinical impact beyond classic allergy-immunology connections and may be associated with extended clinical phenotypes. This suggests an integrative approach to medical practice in allergy patients.

Indexed as

allergyHereditary α-tryptasemiaKITD816V mutationmultisystemicphenotypesymptom burdentryptase

Identifiers

PMID42292655
PMCPMC13254390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.